Assertio Announces Completion of Merger with Zydus Lifesciences and Fundamental Change and Make-Whole Fundamental Change Relating to its Outstanding 6.50% Convertible Senior Notes due 2027

Stock Information for Assertio Holdings Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Assertio Holdings Inc.

Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders?
Shareholder Alert: Ademi LLP investigates whether Assertio Holdings Inc. is obtaining a Fair Price for Public Shareholders
Are SILA, UNF, ASRT, KW Obtaining Fair Deals for their Shareholders?
$HAREHOLDER ALERT: The M&A Class Action Continues to Investigate the Merger--ASRT, SILA, KW, and UNF
Are SEM, UNF, CNTA, ASRT Obtaining Fair Deals for their Shareholders?
Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc. - ASRT
Shareholder Alert: Ademi LLP investigates whether Assertio Holdings Inc. is obtaining a Fair Price for Public Shareholders
Assertio to Be Acquired by Zydus Worldwide DMCC for $23.50 Per Share in Cash

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.